Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. High dose stimulants for attention deficit hyperactivity disorder: clinical effectiveness, safety, and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response. 2015 Authors' conclusions One systematic review, three randomized-controlled trials, and four non-randomized studies were identified regarding high dose stimulants for Attention Deficit Hyperactivity Disorder. Indexing Status Subject indexing assigned by CRD MeSH Amphetamine; Amphetamines; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dexedrine; Dextroamphetamine; Drug Dosage Calculations; Mental Healths; Methylphenidate; Ritalin Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32016000121 Date abstract record published 28/01/2016 |